Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 16776 - 16800 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cidofovir	Approved Investigational	EPRS	2058	downregulated	cidofovir results in decreased expression of EPRS mRNA	1q41	A20427
Cidofovir	Approved Investigational	FAM162A	26355	downregulated	cidofovir results in decreased expression of FAM162A mRNA	3q21.1	A20427
Cidofovir	Approved Investigational	FAM210A	125228	upregulated	cidofovir results in increased expression of FAM210A mRNA	18p11.21	A20427
Cidofovir	Approved Investigational	FAM210B	116151	upregulated	cidofovir results in increased expression of FAM210B mRNA	20q13.2	A20427
Cidofovir	Approved Investigational	FAM212B	55924	upregulated	cidofovir results in increased expression of FAM212B mRNA	1p13.2	A20427
Cidofovir	Approved Investigational	FAM214A	56204	downregulated	cidofovir results in decreased expression of FAM214A mRNA	15q21.2-q21.3	A20427
Cidofovir	Approved Investigational	FAM84B	157638	upregulated	cidofovir results in increased expression of FAM84B mRNA	8q24.21	A20427
Cidofovir	Approved Investigational	FAM89A	375061	upregulated	cidofovir results in increased expression of FAM89A mRNA	1q42.2	A20427
Cidofovir	Approved Investigational	FBXO22	26263	upregulated	cidofovir results in increased expression of FBXO22 mRNA	15q24.2	A20427
Cidofovir	Approved Investigational	FBXO30	84085	downregulated	cidofovir results in decreased expression of FBXO30 mRNA	6q24.3	A20427
Cidofovir	Approved Investigational	FECH	2235	downregulated	cidofovir results in decreased expression of FECH mRNA	18q21.31	A20427
Cidofovir	Approved Investigational	FOSL1	8061	upregulated	cidofovir results in increased expression of FOSL1 mRNA	11q13.1	A20427
Cidofovir	Approved Investigational	FOSL2	2355	downregulated	cidofovir results in decreased expression of FOSL2 mRNA	2p23.2	A20427
Cidofovir	Approved Investigational	FREM2	341640	downregulated	cidofovir results in decreased expression of FREM2 mRNA	13q13.3	A20427
Cidofovir	Approved Investigational	GABARAPL1	23710	downregulated	cidofovir results in decreased expression of GABARAPL1 mRNA	12p13.2	A20427
Cidofovir	Approved Investigational	GARS	2617	upregulated	cidofovir results in increased expression of GARS mRNA	7p14.3	A20427
Cidofovir	Approved Investigational	GBE1	2632	upregulated	cidofovir results in increased expression of GBE1 mRNA	3p12.2	A20427
Cidofovir	Approved Investigational	GCLC	2729	downregulated	cidofovir results in decreased expression of GCLC mRNA	6p12.1	A20427
Cidofovir	Approved Investigational	GCLM	2730	upregulated	cidofovir results in increased expression of GCLM mRNA	1p22.1	A20427
Cidofovir	Approved Investigational	GCNT3	9245	upregulated	cidofovir results in increased expression of GCNT3 mRNA	15q22.2	A20427
Cidofovir	Approved Investigational	GDF15	9518	upregulated	cidofovir results in increased expression of GDF15 mRNA	19p13.11	A20427
Cidofovir	Approved Investigational	GOLIM4	27333	downregulated	cidofovir results in decreased expression of GOLIM4 mRNA	3q26.2	A20427
Cidofovir	Approved Investigational	GOT1	2805	upregulated	cidofovir results in increased expression of GOT1 mRNA	10q24.2	A20427
Cidofovir	Approved Investigational	GPA33	10223	upregulated	cidofovir results in increased expression of GPA33 mRNA	1q24.1	A20427
Cidofovir	Approved Investigational	GPAT3	84803	upregulated	cidofovir results in increased expression of GPAT3 mRNA	4q21.23	A20427

Displaying entries 16776 - 16800 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability